Health & Well-Being

TendoNova develops minimally invasive medical technology for treating chronic tendon conditions, allowing physicians to perform certain procedures in an office setting.

Chronic tendon injuries affect millions of people each year, limiting mobility, reducing quality of life, and often requiring expensive or invasive treatment options. TendoNova was created to expand access to care through minimally invasive medical technology for treating chronic tendon conditions. Its flagship product, the Ocelot Nano System™, allows physicians to perform certain tendon procedures in an office setting, helping reduce barriers associated with more complex surgical interventions. In March 2023, an Abundance Angel recommended a $10,000 investment alongside VentureSouth. The investment supported commercialization efforts, sales expansion, and the continued growth of technology designed to make tendon care more accessible to patients. The company’s approach focuses on providing physicians with lower-cost, office-based treatment options that expand access to care and reduce the burden associated with traditional procedures.